1. In vivo synergy between topoisomerase II and histone deacetylase inhibitors: predictive correlates
   Douglas C. Marchion et al, 2005, Molecular Cancer Therapeutics CrossRef
2. Increased MDR1 Expression in Normal and Malignant Peripheral Blood Mononuclear Cells Obtained from Patients Receiving Depsipeptide (FR901228, FK228, NSC630176)
   Robert W. Robey et al, 2006, Clinical Cancer Research CrossRef
3. Mechanisms of Resistance to Histone Deacetylase Inhibitors and Their Therapeutic Implications
   Valeria R. Fantin et al, 2007, Clinical Cancer Research CrossRef